AU8005201A - Pharmaceutical composition comprising an analgesic peptide - Google Patents

Pharmaceutical composition comprising an analgesic peptide

Info

Publication number
AU8005201A
AU8005201A AU8005201A AU8005201A AU8005201A AU 8005201 A AU8005201 A AU 8005201A AU 8005201 A AU8005201 A AU 8005201A AU 8005201 A AU8005201 A AU 8005201A AU 8005201 A AU8005201 A AU 8005201A
Authority
AU
Australia
Prior art keywords
amino acid
pharmaceutical composition
peptide
trp
null
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8005201A
Other languages
English (en)
Inventor
Aharon Shulov
Naftali Primor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHLOMIT SHULOV BARKAN
Shulov Institute for Science (SIS) Ltd
Original Assignee
SHLOMIT SHULOV BARKAN
Shulov Institute for Science (SIS) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHLOMIT SHULOV BARKAN, Shulov Institute for Science (SIS) Ltd filed Critical SHLOMIT SHULOV BARKAN
Publication of AU8005201A publication Critical patent/AU8005201A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU8005201A 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide Pending AU8005201A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL137820A IL137820A (en) 2000-08-10 2000-08-10 Pharmaceutical composition for topical administration comprising an analgesic peptide
PCT/IL2001/000724 WO2002012269A2 (en) 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide

Publications (1)

Publication Number Publication Date
AU8005201A true AU8005201A (en) 2002-02-18

Family

ID=11074512

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8005201A Pending AU8005201A (en) 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide
AU2001280052A Expired AU2001280052B2 (en) 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001280052A Expired AU2001280052B2 (en) 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide

Country Status (12)

Country Link
US (1) US7220725B2 (cg-RX-API-DMAC7.html)
EP (1) EP1309613B1 (cg-RX-API-DMAC7.html)
JP (1) JP4860096B2 (cg-RX-API-DMAC7.html)
CN (2) CN102160890B (cg-RX-API-DMAC7.html)
AT (1) ATE392428T1 (cg-RX-API-DMAC7.html)
AU (2) AU8005201A (cg-RX-API-DMAC7.html)
CA (1) CA2418793C (cg-RX-API-DMAC7.html)
DE (1) DE60133654T2 (cg-RX-API-DMAC7.html)
DK (1) DK1309613T3 (cg-RX-API-DMAC7.html)
ES (1) ES2305096T3 (cg-RX-API-DMAC7.html)
IL (1) IL137820A (cg-RX-API-DMAC7.html)
WO (1) WO2002012269A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
US8252754B2 (en) * 2005-03-21 2012-08-28 The Trustees Of Columbia University In The City Of New York Neuronal pain pathway
US20100190723A1 (en) * 2007-03-23 2010-07-29 Hiroo Sanada Preventive or therapeutic composition for liver disease
US20110183925A1 (en) * 2008-09-22 2011-07-28 Nisshin Pharma Inc. Anti-inflammatory peptide
CN102686221B (zh) 2009-07-27 2018-04-17 诺西赛普塔有限责任公司 治疗疼痛的方法
FR2948809B1 (fr) * 2009-07-31 2012-08-17 St Microelectronics Rousset Amplificateur de lecture faible puissance auto-minute
ES2598829T3 (es) * 2011-03-28 2017-01-30 S.I.S. Shulov Innovative Science Ltd. Procedimiento de tratamiento de trastornos cutáneos
CN107847552B (zh) 2015-01-07 2022-07-01 三叉神经股份公司 含镁的催产素制剂和使用方法
EP4541348A3 (en) 2016-04-12 2025-06-04 Tonix Pharma Limited Magnesium-containing oxytocin formulations and methods of use
RU2669386C1 (ru) * 2017-08-11 2018-10-11 Закрытое акционерное общество "Институт экспериментальной фармакологии" Состав и способ получения анальгетического средства пептидной структуры
KR20200138326A (ko) 2018-03-29 2020-12-09 에스.아이.에스. 슐로브 이노베이티브 사이언스 리미티드 염증성 시토카인을 억제하기 위한 약제학적 조성물
US11644463B2 (en) 2019-08-30 2023-05-09 Euroimmun Medizinische Labordiagnostika Ag Detection of an autoantibody
AU2020356605A1 (en) * 2019-09-26 2022-04-14 S.I.S. Shulov Innovative Science Ltd. Anti-aging compositions and methods of use thereof
WO2021059267A1 (en) * 2019-09-26 2021-04-01 S.I.S. Shulov Innovative Science Ltd. Compositions and methods for treating degenerative, age-related and trauma-induced disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491541A (en) * 1982-11-10 1985-01-01 Farmitalia Carlo Erba Peptides
IT1172391B (it) * 1983-12-23 1987-06-18 Polifarma Spa Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche
JPH0680079B2 (ja) * 1984-11-09 1994-10-12 エーザイ株式会社 ポリペプチド
IT1242002B (it) * 1990-10-03 1994-02-02 Polifarma Spa Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido quello centrale
EP0668770A1 (en) 1991-04-24 1995-08-30 Warner-Lambert Company $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
AUPM489194A0 (en) * 1994-04-07 1994-04-28 Luminis Pty Limited Peptides
RU2107691C1 (ru) * 1995-03-02 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US5776896A (en) * 1996-01-03 1998-07-07 Zeneca Limited Analgesic peptides from venom of grammostola spatulata and use thereof
AU3136897A (en) * 1996-05-22 1997-12-09 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
US6126939A (en) * 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
IL123001A (en) * 1998-01-20 1998-12-06 Shulov Inst For Venom Research Analgesic fraction from snake March and pharmacy preparations containing it
CA2341810A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide

Also Published As

Publication number Publication date
CA2418793A1 (en) 2002-02-14
EP1309613A2 (en) 2003-05-14
CA2418793C (en) 2011-11-15
CN1462277A (zh) 2003-12-17
JP2004513079A (ja) 2004-04-30
CN102160890B (zh) 2013-02-06
DE60133654T2 (de) 2009-06-04
US7220725B2 (en) 2007-05-22
AU2001280052B2 (en) 2007-11-29
IL137820A0 (en) 2001-10-31
JP4860096B2 (ja) 2012-01-25
DE60133654D1 (de) 2008-05-29
ATE392428T1 (de) 2008-05-15
IL137820A (en) 2009-06-15
EP1309613B1 (en) 2008-04-16
CN102160890A (zh) 2011-08-24
US20040014673A1 (en) 2004-01-22
WO2002012269A3 (en) 2002-12-19
HK1160778A1 (en) 2012-08-17
WO2002012269A2 (en) 2002-02-14
DK1309613T3 (da) 2008-08-11
ES2305096T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
IL137820A0 (en) Pharmaceutical composition comprising an analgesic peptide
WO2002047715A3 (en) Compositions of peptide crystals
Ljungqvist et al. Antide and related antagonists of luteinizing hormone release with long action and oral activity.
CA2370289A1 (en) Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
AU2000277238A1 (en) Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy
US4742156A (en) Peptide antagonists of neurokinin B and opthalmic solutions containing them
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
IE57698B1 (en) Modified protease inhibitors,process for their preparation,and pharmaceutical compositions prepared therefrom
MY139203A (en) Pharmaceutical composition
AU1377092A (en) Peptides for treatment
JP2004513079A5 (cg-RX-API-DMAC7.html)
DK1173476T3 (da) Funktionelle sojabönneproteiner
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
EP0219258A2 (en) Peptide antagonists of Neurokinin B and opthalmic solutions containing them
NO952635L (no) Syntetiske peptidderivater og salter derav
RU93050068A (ru) Циклопептиды, способ их получения, фармацевтические композиции и способ их получения, способ лечения
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
CA2102447A1 (en) Cyclopeptides
CA2423004A1 (en) Peptide inhibitors of hiv entry
AU2001266441A1 (en) Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
KR101410589B1 (ko) 뉴로펩타이드 유도체 및 이를 함유하는 피부 외용제 조성물
JP2023519935A (ja) 皮膚症状に用いるためのアセチルコリンエステラーゼのｃ末端に由来するポリペプチド
US5593965A (en) Anti-tumor effects of GnRH-III
US4948873A (en) Gonadoliberine analogues of high activity